Applied DNA Sciences, Inc.
Hedge Funds Holdings
Last updated:
Applied DNA Sciences, Inc.‘s stocks are currently a part of 18 hedge funds’ portfolios, which represents 8.85% of the total amount of its stocks outstanding. This makes up a total of 1.14M shares of Applied DNA Sciences, Inc.. Compared to the previous quarter, the number fell by -42.99% or -862.04K shares fewer. As for the holding position changes, 27.78% (5) of current hedge fund investors increased the number of shares held, 11.11% (2) of current holders sold a part of the shares held. 5 hedge funds are new holders of Applied DNA Sciences, Inc. stock in Q1 2023, it is 27.78% of total holders.
Hedge funds holding Applied DNA Sciences (Q2 2018 – Q1 2023)
| Q2 2018 | 32 |
|---|---|
| Q3 2018 | 33 |
| Q4 2018 | 24 |
| Q1 2019 | 22 |
| Q2 2019 | 22 |
| Q3 2019 | 24 |
| Q4 2019 | 8 |
| Q1 2020 | 12 |
| Q2 2020 | 14 |
| Q3 2020 | 14 |
| Q4 2020 | 15 |
| Q1 2021 | 15 |
| Q2 2021 | 13 |
| Q3 2021 | 12 |
| Q4 2021 | 17 |
| Q1 2022 | 15 |
| Q2 2022 | 19 |
| Q3 2022 | 24 |
| Q4 2022 | 24 |
| Q1 2023 | 18 |
Hedge funds changes in Applied DNA Sciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 4 | 4 | 6 | 3 | 15 |
|---|---|---|---|---|---|
| Q3 2018 | 6 | 6 | 3 | 5 | 13 |
| Q4 2018 | 3 | 3 | 3 | 11 | 4 |
| Q1 2019 | 4 | 4 | 2 | 5 | 7 |
| Q2 2019 | 4 | 0 | 3 | 4 | 11 |
| Q3 2019 | 7 | 3 | 1 | 5 | 8 |
| Q4 2019 | 8 | 0 | 0 | 24 | -24 |
| Q1 2020 | 7 | 3 | 0 | 3 | -1 |
| Q2 2020 | 7 | 6 | 1 | 5 | -5 |
| Q3 2020 | 5 | 4 | 3 | 5 | -3 |
| Q4 2020 | 5 | 5 | 1 | 4 | 0 |
| Q1 2021 | 4 | 7 | 2 | 4 | -2 |
| Q2 2021 | 3 | 7 | 3 | 5 | -5 |
| Q3 2021 | 1 | 9 | 1 | 2 | -1 |
| Q4 2021 | 6 | 5 | 3 | 2 | 1 |
| Q1 2022 | 4 | 4 | 5 | 6 | -4 |
| Q2 2022 | 7 | 1 | 6 | 3 | 2 |
| Q3 2022 | 12 | 8 | 3 | 7 | -6 |
| Q4 2022 | 5 | 7 | 5 | 5 | 2 |
| Q1 2023 | 5 | 5 | 2 | 0 | 6 |
Hedge funds changes in Applied DNA Sciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 19,000 | 0 |
|---|---|---|
| Q3 2018 | 72,000 | 0 |
| Q4 2018 | 20,000 | 0 |
| Q1 2019 | 17,000 | 32,000 |
| Q2 2019 | 7,000 | 78,000 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 906,000 | 57,000 |
| Q4 2021 | 497,000 | 283,000 |
| Q1 2022 | 40,000 | 5,000 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 382,000 | 999,000 |
| Q4 2022 | 410,256 | 607,594 |
| Q1 2023 | 33,565,000 | 3,390,000 |